Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06269614 · ClinicalTrials.gov registry record · NA
Assessing the Gut Microbiome and Its Association With Pediatric Stress and Cognition
A NA study of Autism Spectrum Disorder and Adverse Childhood Experiences, sponsored by Nova Southeastern University.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT06269614: Active NA study of Autism Spectrum Disorder and Adverse Childhood Experiences, sponsored by Nova Southeastern University.
NCT06269614 is a NA study of Autism Spectrum Disorder and Adverse Childhood Experiences that is active but no longer recruiting, run by Nova Southeastern University. The registered enrollment target is 75 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06269614, a NA study of Autism Spectrum Disorder and Adverse Childhood Experiences, is active but no longer recruiting, sponsored by Nova Southeastern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a metabolomics approach in combination with eye-tracking data, this research study proposes to gather evidence from two interrelated body systems (gut and brain) in order to assess how the microbiome is involved in stress modulated symptoms in children with autism and children exposed to repeated stress in comparison to a control group.
Primary Outcome
Increase in gut microbiome abundance (from stool samples) based on values from statistical methods, Analysis of Variance to compare differential abundance analysis.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Probiotic
Study Locations (1)
Florida
- Nova Southeastern University College of Nursing - Davie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2023-01-12 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT06269614 still lists
NCT06269614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (44% lower).
The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Probiotic is the first listed.
NCT06269614 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06269614 about?
NCT06269614 is a clinical study titled "Assessing the Gut Microbiome and Its Association With Pediatric Stress and Cognition". Using a metabolomics approach in combination with eye-tracking data, this research study proposes to gather evidence from two interrelated body systems (gut and brain) in order to assess how the microbiome is involved in stress modulated symptoms in children with autism and children exposed to repea...
What is the current status of trial NCT06269614?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2023-01-12. Estimated completion is 2027-12-31.
What conditions does trial NCT06269614 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Adverse Childhood Experiences, Stress Reaction.
What interventions are being tested in trial NCT06269614?
The interventions under investigation include: Probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06269614?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06269614 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06269614's enrollment target sits among peer trials
75 100th of 224 higher than 122 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI